Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Biotech
Molecular glue biotech f5 Therapeutics closes down
Molecular glue-focused biotech f5 Therapeutics has failed to stick around for the long haul, shuttering after six years.
Gabrielle Masson
Mar 10, 2026 1:10pm
How Jeff Legos builds Pfizer’s oncology future
Mar 4, 2026 2:00pm
BioAtla lays off 70% of workforce, seeks buyers for antibodies
Mar 2, 2026 9:40am
BioNTech’s B7-H3 ADC hits ph. 3 at half the size of Merck’s
Feb 27, 2026 10:31pm
Earendil pens $885M pact to use WuXi XDC's linker tech for ADCs
Feb 27, 2026 5:30am
BMS' ADC hits primary endpoints in phase 3 breast cancer trial
Feb 26, 2026 9:08am
